Grand challenge commentary: Informative diagnostics for personalized medicine
- PMID: 21079587
- PMCID: PMC3116710
- DOI: 10.1038/nchembio.488
Grand challenge commentary: Informative diagnostics for personalized medicine
Abstract
Some of the most celebrated triumphs of chemical biology are molecularly targeted therapeutics to combat human disease. However, a grand challenge looms as informative diagnostic strategies must be developed to realize the full impact of these promising pharmaceutical agents.
Figures
References
-
- Consortium IHGS. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. - PubMed
-
- Venter JC, et al. The sequence of the human genome. Science. 2001;291:1304–1351. - PubMed
-
- Druker BJ, et al. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia. N Engl J Med. 2001;344:1031–1037. - PubMed
-
- Lynch TL, et al. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib. N Engl J Med. 2004;350:2129–2139. - PubMed
-
- Paez JG, et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy. Science. 2004;304:1497–1500. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
